Baotou Central Hospital
13
5
5
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
15%
2 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
The Chinese Familial Alzheimer's Network
Role: collaborator
China Cognition and Aging Study
Role: collaborator
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
Role: collaborator
Hemoadsorption for Severe Ischemic Stroke
Role: collaborator
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Role: collaborator
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
Role: collaborator
Clinical Characteristics and Prognosis of Acute Stroke in Pregnancy and Puerperium
Role: collaborator
Basilar Artery Occlusion Chinese Endovascular Trial
Role: collaborator
Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)
Role: collaborator
Complete Revascularization Via Inferior Part-sternotomy
Role: collaborator
Chinese Research Group of Gallbladder Cancer
Role: collaborator
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)
Role: collaborator
Vascular Ultrasound Screening in Patients With Ischemic Cerebrovascular Disease: a Multi-center Registry Study
Role: collaborator
All 13 trials loaded